Recombinant multi-species DCLK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DCLK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the protein kinase superfamily and the doublecortin family. The protein encoded by this gene contains two N-terminal doublecortin domains, which bind microtubules and regulate microtubule polymerization, a C-terminal serine/threonine protein kinase domain, which shows substantial homology to Ca2+/calmodulin-dependent protein kinase, and a serine/proline-rich domain in between the doublecortin and the protein kinase domains, which mediates multiple protein-protein interactions. The microtubule-polymerizing activity of the encoded protein is independent of its protein kinase activity. The encoded protein is involved in several different cellular processes, including neuronal migration, retrograde transport, neuronal apoptosis and neurogenesis. This gene is up-regulated by brain-derived neurotrophic factor and associated with memory and general cognitive abilities. Multiple transcript variants generated by two alternative promoter usage and alternative splicing have been reported, but the full-length nature and biological validity of some variants have not been defined. These variants encode different isoforms, which are differentially expressed and have different kinase activities.[provided by RefSeq, Sep 2010]
The Alternative Names of target: 1700113D08Rik,2810480F11Rik,Ania4,CL1,CLICK1,Click-I,Cpg16,DCAMKL1,DCDC3A,DCLK,DCLK1,Dcamkl1,Dcl,Dclk,Dclk1,Doublecortin domain-containing protein 3A,Doublecortin-like and CAM kinase-like 1,Doublecortin-like kinase 1,Serine/threonine-protein kinase DCLK1,mKIAA0369
Go
to DCLK1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0115-Ag-1/ GM-Tg-hg-IP0115-Ag-2 | Human DCLK1 protein | Human |
GM-Tg-rg-IP0115-Ag-1/ GM-Tg-rg-IP0115-Ag-2 | Rat DCLK1 protein | Rat |
GM-Tg-mg-IP0115-Ag-1/ GM-Tg-mg-IP0115-Ag-2 | Mouse DCLK1 protein | Mouse |
GM-Tg-cynog-IP0115-Ag-1/ GM-Tg-cynog-IP0115-Ag-2 | Cynomolgus/Rhesus macaque DCLK1 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0115-Ag-1/ GM-Tg-felg-IP0115-Ag-2 | Feline DCLK1 protein | Feline |
GM-Tg-cang-IP0115-Ag-1/ GM-Tg-cang-IP0115-Ag-2 | Canine DCLK1 protein | Canine |
GM-Tg-bovg-IP0115-Ag-1/ GM-Tg-bovg-IP0115-Ag-2 | Bovine DCLK1 protein | Bovine |
GM-Tg-equg-IP0115-Ag-1/ GM-Tg-equg-IP0115-Ag-2 | Equine DCLK1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP0115-Ag-1/ GM-Tg-hg-IP0115-Ag-2;
GM-Tg-rg-IP0115-Ag-1/ GM-Tg-rg-IP0115-Ag-2;
GM-Tg-mg-IP0115-Ag-1/ GM-Tg-mg-IP0115-Ag-2; GM-Tg-cynog-IP0115-Ag-1/ GM-Tg-cynog-IP0115-Ag-2; GM-Tg-felg-IP0115-Ag-1/ GM-Tg-felg-IP0115-Ag-2; GM-Tg-cang-IP0115-Ag-1/ GM-Tg-cang-IP0115-Ag-2; GM-Tg-bovg-IP0115-Ag-1/ GM-Tg-bovg-IP0115-Ag-2; GM-Tg-equg-IP0115-Ag-1/ GM-Tg-equg-IP0115-Ag-2 |
Products Name | DCLK1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | DCLK1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DCLK1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.